title: Interferon alpha in the therapy of conjunctival lymphoma in an HIV+ patient.
abstract: The authors evaluated the efficacy of interferon-alpha used intralesionally in the therapy of low-grade conjunctival non-Hodgkin lymphoma in an HIV-positive patient. The patient received one intralesional injection of 1,000,000 U of interferon-alpha three times a week for a total of twelve doses. The remission of conjunctival involvement was seen three months from the end of therapy. The intralesional use of interferon-alpha can be considered an efficacious therapy for low-grade conjunctival non-Hodgkin lymphoma.
authors.affiliation: Institute of Ophthalmology, University of Bologna, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cellini
authors.forename: G L
authors.initials: GL
authors.lastname: Possati
authors.forename: P
authors.initials: P
authors.lastname: Puddu
authors.forename: R
authors.initials: R
authors.lastname: Caramazza
mesh_terms: D003230:Conjunctival Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D006679:HIV Seropositivity / Q000150:complications*; D006801:Humans; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000627:therapeutic use*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D016898:Interferon-alpha